Augmedix to Announce Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call on March 27, 2023
Augmedix (Nasdaq: AUGX) will report its financial results for Q4 and the full year ending December 31, 2022, on March 27, 2023, before the market opens. The company's management will host a conference call at 5:00 a.m. PT / 8:00 a.m. ET. Live audio of this event will be accessible on the company’s website. Additionally, CEO Manny Krakaris and Founder Ian Shakil will attend the ViVE Conference in Nashville, TN, on March 27-28, 2023. Augmedix specializes in ambient medical documentation and data solutions, aiming to reduce clinician burnout and enhance patient satisfaction by automating the creation of medical notes.
- Scheduled financial results announcement for Q4 and full year 2022.
- Participation in ViVE Conference, enhancing visibility in healthcare technology.
- None.
Company also announces participation in the ViVE Conference in Nashville, TN, on March 27-28, 2023
SAN FRANCISCO, March 16, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced it will report financial results for the fourth quarter and full-year ended December 31, 2022 on Monday, March 27, 2023, before the market opens. Company management will host a conference call that day at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time.
Live audio of the conference call will be available on the “Events” section of the Company’s website at: https://ir.augmedix.com/news-events. The webcast will be archived and available for replay after the event.
Additionally, Manny Krakaris, Chief Executive Officer, and Ian Shakil, Founder and Chief Strategy Officer, will attend the ViVE Conference in Nashville, TN, on March 27-28, 2023. The industry conference is targeted at senior digital health leaders focused on healthcare systems. Attending investors interested in meeting with Augmedix can contact the IR team at investors@augmedix.com.
About Augmedix
Augmedix (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions remotely to healthcare systems, physician practices, hospitals, and telemedicine practitioners.
Augmedix is on a mission to help clinicians and patients form a human connection at the point of care with seamless technology. Augmedix’s proprietary Notebuilder Platform extracts relevant data from natural clinician-patient conversations and converts that data into medical notes in real time, which are seamlessly transferred to the EHR. The company’s platform uses Automatic Speech Recognition, Natural Language Processing, including Large Language Models, and Medical Documentation Specialists to generate accurate and timely medical notes to healthcare providers.
Leveraging this platform, Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of physician-patient interactions and analyzing them to deliver actionable insights that elevate patient care.
Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
(646) 809-2183
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
FAQ
When will Augmedix report its financial results for Q4 2022?
What is the significance of Augmedix's participation in the ViVE Conference?
What time is Augmedix's conference call for financial results?
What are Augmedix's main products?
